GSK3A and cancer: To define the mechanism linking Rai to PD-1 upregulation we focused on the enzyme GSK-3α/β, a central regulator of PD-1 expression in T cells, whose CD28/TCR-dependent phospho-inactivation has been shown to repress pdcd1 transcription and to enhance cancer clearance [15, 19].